Online Programs to Promote Colon Cancer Screening
|Colon Cancer Screening||Behavioral: Information + Narratives + Support Group Behavioral: Information Only|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Online Programs to Promote Colon Cancer Screening|
- Feasibility [ Time Frame: 6 months ]Feasibility of recruitment, randomization, intervention delivery, retention, and assessment of colon cancer screening status
- Colon cancer screening attitudes [ Time Frame: 6 months ]
|Study Start Date:||July 2011|
|Study Completion Date:||May 2012|
|Primary Completion Date:||May 2012 (Final data collection date for primary outcome measure)|
|Active Comparator: Information||
Behavioral: Information Only
Information from CDC website on colon cancer screening.
|Experimental: Information + Narratives + Support group||
Behavioral: Information + Narratives + Support Group
Information from CDC website Narratives about CRCS written by others Peer social support among study participants
Participants in the control group will view standard online information about colon cancer screening. Participants in the intervention group will view the same information and also will be invited to sign on to the online website and interact with peer supporters at their convenience. They will have 6 months to communicate with peer supporters. Peer supporters are encouraged to address comments and concerns of the study participants.
About 300 study participants, majority white, female. Inclusion criteria: age 50-75, not currently meeting colorectal cancer screening guidelines, no previous colorectal cancer.
The study will also include 15 previously identified peer supporters.
Recruitment: Administrators of the SparkPeople.com weight loss community will send study recruitment emails to members at least 50 years of age. Interested individuals will pass an eligibility screening and provide informed consent.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01411826
|United States, Texas|
|University of Texas Health Science Center at Houston|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Kevin Hwang, MD||The University of Texas Health Science Center, Houston|